Hilleman Insights | Hilleman Laboratories - Medical Research Organization

Hilleman Laboratories to lead development of an mRNA vaccine for hand, foot, and mouth disease

At the recent World Health Organization and Medicines Patent Pool mRNA Technology Transfer Programme meeting in Singapore...

The World Faces More Vaccine Challenges Than Just COVID-19

After the traumatic experiences of the first year of COVID-19 pandemic we now have an idea of what a world without vaccines could be like.

The Threat of Infectious Diseases in Asia Pacific

Asia Pacific is home to more than half of the world’s population and bears a significant burden of infectious disease, particularly in the low-and-middle-income countries (LMICs).

Hilleman Laboratories establishes pilot manufacturing facility for vaccine development in Singapore with support from Singapore Economic Development Board

The Importance of Innovation to Improve Vaccine Equity and Access for Future Pandemics

The COVID-19 pandemic has shown science at its best as we witnessed the rapid development of vaccines